We are live on ! Find out more
TBRA

Tobira Therapeutics, Inc. Common Stock
TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of TBRA yet.

TBRA Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q4 2016, worth a combined $0 — down 100% from $505M a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of TBRA and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $147M sold.

  • 0 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q4 2016, down from 68 in Q3 2016.
  • Funds reported $0 of Tobira Therapeutics, Inc. Common Stock stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q4 2016 and 67 closed out, a net change of -67 holders.
  • The largest Tobira Therapeutics, Inc. Common Stock seller in Q4 2016 was Pentwater Capital Management, an estimated $147M sold.

Based on aggregated 13F filings for Q4 2016.